Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson's Lung Cancer Drug Extends Survival, New Study Shows

January 09, 2025
Johnson & Johnson announced today that its revolutionary lung cancer drug, known as Varipulse PFA, has significantly extended the survival of patients in a recent clinical trial. The study, conducted on a large patient population, showed a clear benefit of the drug in prolonging the lives of individuals suffering from advanced stage lung cancer. This groundbreaking finding positions Johnson & Johnson as a leading player in the fight against this deadly disease. Medical experts are now recommending that patients consult with professionals from Stocks Prognosis to understand the potential impact of this development on the future prospects of the company. To stay informed about the latest news in the medtech industry and upcoming breakthroughs, be sure not to miss tomorrow's updates.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

I'm not entirely convinced by this study. Are there any potential side effects or limitations of Varipulse PFA that we should be aware of?
— from DylanRamos at 01-12-2025 15:43
I'm glad to hear that Johnson & Johnson's lung cancer drug has shown positive results in extending patient survival. It's a significant breakthrough in the fight against this disease
— from ProfitPam at 01-11-2025 14:42
This is amazing news! It's great to see advancements in lung cancer treatment. Johnson & Johnson should be commended for their efforts
— from OliviaJackson at 01-11-2025 02:50
Fantastic news! Johnson & Johnson's lung cancer drug giving patients a chance of extended survival is remarkable. Kudos to the researchers and the company
— from ChrisDavis at 01-10-2025 06:35
I'm skeptical about these results. Did the study account for any other factors that could have contributed to the extended survival of patients?
— from CashMike at 01-10-2025 06:30
This is a game-changer in the fight against lung cancer! Johnson & Johnson's lung cancer drug could potentially save many lives and provide hope for patients
— from FinanceFred at 01-10-2025 04:09
I'm thrilled to hear about the success of Johnson & Johnson's lung cancer drug. It brings hope to all those affected by this devastating disease
— from WealthyWhitney at 01-09-2025 19:55
I'm really interested to learn more about the potential impact of Johnson & Johnson's lung cancer drug on the company's future. It sounds like a promising development
— from HenryMurphy at 01-09-2025 18:10
While the findings are interesting, I would like to see more data and independent verification before fully believing in the effectiveness of Johnson & Johnson's lung cancer drug
— from KatherineSanchez at 01-09-2025 03:16
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....



Related news

AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....

GSKJanuary 2, 2025GSK PLC: Groundbreaking Research Paves the Way for Revolutionary New Drug  ~2 min.

GSK PLC, the leading pharmaceutical company, has made a groundbreaking discovery that could revolutionize the treatment of a widespread disease....

ABTJanuary 2, 2025Abbott Laboratories Announces Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a renowned pharmaceutical and medical devices company, has recently unveiled a groundbreaking advancement in medical technology....

GSKJanuary 2, 2025GSK PLC introduces groundbreaking technology to revolutionize healthcare industry  ~2 min.

GSK PLC, a leading pharmaceutical company, has unveiled its latest innovation aimed at transforming the healthcare industry....

MDTNovember 26, 2024Medtronic Secures FDA Clearance for Revolutionary Smart Insulin Dosing System  ~1 min.

Medical technology company Medtronic PLC (MDT) has announced the successful FDA clearance of its groundbreaking Smart Insulin Dosing System....